Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion type Assertion NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_head.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion description "[HER2 overexpression is a hallmark of a particularly aggressive subset of breast tumors, and its activation is strictly dependent on the trans-interaction with other members of HER family; in particular, the activation of the PI3K/Akt survival pathway, so critically important in tumorigenesis, is predominantly driven through phosphorylation of the kinase-inactive member HER3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_provenance.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion evidence source_evidence_literature NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_provenance.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion SIO_000772 19276373 NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_provenance.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion wasDerivedFrom befree-2016 NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_provenance.
- NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_assertion wasGeneratedBy ECO_0000203 NP725167.RAJeFs8KMa3HsLgiugfCjVLWE6cg-Yi5NPFLkDVZfbOiU130_provenance.